drugset / Trial / NCT07044401
A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices
RandomizedCrossoverOpen-labelBasic science
Summary
The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared to the abdomen.
Timeline
- Start
- 2025-07-14
- Primary completion
- 2025-11-13
- Completion
- 2025-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KAI-9531 | Unknown | — | Subcutaneous |
Indications
No indication recorded.